National Health Investors (NYSE:NHI) Lowered to Strong Sell Rating by Zacks Research

Posted by Francis Steltz on Jun 27th, 2026

National Health Investors (NYSE:NHI – Get Free Report) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Thursday,Zacks.com reports.

A number of other analysts have also issued reports on the company. BMO Capital Markets dropped their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Truist Financial lowered their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Deutsche Bank Aktiengesellschaft dropped their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 target price on shares of National Health Investors in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $83.86.

View Our Latest Research Report on NHI

National Health Investors Price Performance

NHI opened at $77.58 on Thursday. The company has a fifty day simple moving average of $74.89 and a 200 day simple moving average of $79.64. The firm has a market cap of $3.76 billion, a price-to-earnings ratio of 25.02, a PEG ratio of 4.15 and a beta of 0.52. National Health Investors has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The firm had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The business’s quarterly revenue was up 28.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts expect that National Health Investors will post 4.87 EPS for the current fiscal year.

Insider Activity

In other news, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors have recently made changes to their positions in NHI. State Street Corp raised its position in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after acquiring an additional 95,812 shares in the last quarter. Principal Financial Group Inc. lifted its stake in National Health Investors by 2.0% during the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after purchasing an additional 32,902 shares during the last quarter. Geode Capital Management LLC boosted its holdings in National Health Investors by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock worth $96,443,000 after purchasing an additional 18,198 shares during the period. Centersquare Investment Management LLC boosted its holdings in National Health Investors by 17.0% in the fourth quarter. Centersquare Investment Management LLC now owns 1,154,060 shares of the real estate investment trust’s stock worth $88,136,000 after purchasing an additional 167,352 shares during the period. Finally, Bank of America Corp DE increased its stake in National Health Investors by 20.0% during the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock valued at $80,278,000 after purchasing an additional 165,467 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.